|
OIP5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.4432899320127E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.53079999999762E-05 |
| Normal-vs-Stage2 |
3.761700E-02 |
| Normal-vs-Stage3 |
1.92104999999776E-05 |
| Normal-vs-Stage4 |
2.657500E-03 |
| Stage1-vs-Stage2 |
7.653400E-01 |
| Stage1-vs-Stage3 |
6.201300E-03 |
| Stage1-vs-Stage4 |
8.078000E-03 |
| Stage2-vs-Stage3 |
7.072000E-02 |
| Stage2-vs-Stage4 |
3.292000E-02 |
| Stage3-vs-Stage4 |
4.230000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.08939565438504E-11 |
| Normal-vs-AfricanAmerican |
2.85200000005315E-06 |
| Normal-vs-Asian |
9.478100E-02 |
| Caucasian-vs-AfricanAmerican |
5.557000E-01 |
| Caucasian-vs-Asian |
2.110600E-01 |
| AfricanAmerican-vs-Asian |
2.934400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.68787206433763E-12 |
| Normal-vs-Female |
2.4962999999989E-05 |
| Male-vs-Female |
7.459500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.030700E-04 |
| Normal-vs-Extreme_Weight |
4.12190004350776E-09 |
| Normal-vs-Obese |
3.49300000035413E-07 |
| Normal-vs-Extreme_Obese |
1.806160E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.343840E-01 |
| Normal_Weight-vs-Obese |
5.024000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.461980E-02 |
| Extreme_Weight-vs-Obese |
2.276200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.711800E-02 |
| Obese-vs-Extreme_Obese |
9.758500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.257700E-03 |
| Normal-vs-Age(41-60Yrs) |
9.94050397551405E-11 |
| Normal-vs-Age(61-80Yrs) |
3.70449999997913E-06 |
| Normal-vs-Age(81-100Yrs) |
6.982300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.206040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.005700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.382000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.077400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.909800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.690000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.90979995443541E-09 |
| Normal-VS-Type2 PRCC |
9.21730000102983E-08 |
| Normal-VS-KIRP CIMP |
7.612600E-04 |
| Normal-VS-Unclassified PRCC |
1.06140000000199E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.111600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.880600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.696600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.06700000000049E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.913590E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.600600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.88843999999744E-05 |
| Normal-vs-N1 |
6.40279999999382E-05 |
| Normal-vs-N2 |
1.061230E-01 |
| N0-vs-N1 |
3.199200E-03 |
| N0-vs-N2 |
6.141800E-02 |
| N1-vs-N2 |
6.528800E-01 |
|
|
